Cancer Pain

Study reveals benefits of drug pump

Published in Cancer Weekly, November 19th, 2002

When it comes to treating cancer pain with powerful painkillers, the delivery method can make a major difference in patient outcomes, according to the results of a landmark study published in the Journal of Clinical Oncology.

Sponsored by Medtronic, Inc., (MDT) the study showed that opioids delivered through an implantable infusion system provided better relief from moderate to severe cancer pain with smaller doses and significantly fewer side effects than standard treatments (like pills, patches and shots) alone. Intrathecal infusion - delivery of medication directly into the fluid surrounding the spinal cord, where nerve cells that regulate pain are located -...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2002-11-19)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry